HEALTH

New products boost external analgesic rubs
Quest Products is looking to break onto the external analgesic scene with CopperFixx, a balm that combines the analgesic properties associated with copper and arnica. “Copper has always been known to help relieve the aches and pains of certain afflictions,” said Don Ryan, president and CEO of Quest Products. “Until now, no one had figured out how to produce it in a consumer-friendly form.”
Hamacher Resource Group serving as feature keynote at ECRM’s Health Care EPPS
WAUKESHA, Wis. – Hamacher Resource Group will be the feature keynote at ECRM’s Health Care EPPS, on Sept. 11. Dave Wendland, VP strategic relations and member of the owners group at HRG, will discuss the new item launch journey through the lens of HRG’s Concept through Commercialization methodology.

Pre-workout category emerging as a destination category for mass retailers

OVIEDO, Fla. - The pre-workout category is beginning to emerge as a viable destination center within mass outlets, Nutrex Research reported recently. At the National Associaton of Chain Drug Stores Total Store Expo last month, Nutrex showcased its OutLift pre-workout supplement, available in a blackberry lemonade flavor.
Improving outcomes through patient motivation

Johnson & Johnson’s president of health and wellness solutions Len Greer

The main focus for Johnson & Johnson’s health and wellness solutions president Len Greer is getting patients motivated to improve overall health outcomes. Aside from the company’s partnership with IBM Watson, Greer said Johnson & Johnson is undertaking efforts to apply behavioral science in such disease states as diabetes, cancer and cardiovascular disease to improve patient health.
J&J showcases new diabetes approach

The front-end opportunity surrounding patients with diabetes is significant. Diabetes patients are spending between $1,000 and $2,500 each year on diabetes supplies alone, noted Sally Manoufar, senior manager health and wellness at Johnson & Johnson, during a recent GMDC webcast. According to Johnson & Johnson research, the front-end basket of a diabetes patient is five times larger than that of a patient who doesn’t have diabetes.
Nexium 24HR remains leader ahead of private-label launches

Pfizer’s Nexium 24HR is the clear leader in the digestive aisle. However, in March 2017, store-brand versions of Nexium 24HR will be available. Perrigo has already secured a tentative approval from the Food and Drug Administration for its OTC Nexium 24HR generic equivalent. “We are currently working with our retail customers in making plans to launch the item as soon as possible after the late March 2017 market exclusivity period expires for the national brand,” John Henderickson, Perrigo president and CEO, recently told investors.
Hyland’s Good Morning boosts energy naturally

CARSON, Calif. — Hyland’s at NACDS Total Store Expo launched a new homeopathic energy booster called Good Morning that targets consumers looking for a natural revitalization solution, following a night of tossing and turning in bed. Good Morning contains no caffeine, is stimulant free and is non-habit forming. According to Hyland’s research, 38.3% of Americans have trouble sleeping, with stress being the leading cause of their restlessness.
CRN adds digital marketing expert to speaker card for annual conference

WASHINGTON — The Council for Responsible Nutrition on Wednesday announced that Mitch Joel, president of Mirum — a global digital marketing agency — best-selling author and digital marketing expert, will speak at The Conference: CRN’s Annual Symposium for the Dietary Supplement Industry.
Teaching consumers to lead healthier lives

When RB North America president Alexander Lacik thinks about his 18-year-old son, he doesn’t doubt that it’s possible he might live longer than 100 years. His concern is where his son will get the knowledge to lead a healthy lifestyle — something Lacik said could be a big role for Walmart, particularly in the vitamins, minerals and supplements category.
No. 1 Flonase to face strong competition

The allergy space will continue to heat up significantly in 2017 as marketers pollinate the airwaves with advertisements promoting their latest brand introductions. GSK Consumer Healthcare will have its hands full defending the Flonase franchise, now the No. 1 allergy remedy on the market. Not only is there another nasal corticosteroid on the market — McNeil Consumer’s Rhinocort launched earlier this year — but Flonase faces increasing private-label and brand competition.